Vacca Giada, Ahn Soyon, Phillips Anthony G
Department of Psychiatry, Institute of Mental Health, University of British Columbia, Vancouver, BC, Canada.
Neuropsychopharmacology. 2007 Apr;32(4):932-9. doi: 10.1038/sj.npp.1301173. Epub 2006 Aug 2.
Abstinence from high doses of psychostimulant drugs, in both humans and rodents, is linked to adverse psychological effects including anhedonia, a core symptom of major depression, manifested behaviorally as decreased responding for rewarding stimuli. The present study used brain microdialysis in freely moving rats to examine the effect of D-amphetamine (D-amph) withdrawal on changes in extracellular dopamine (DA) levels in the nucleus accumbens (NAc) evoked by D-amph or behavior related to sucrose consumption. D-amph was administered intraperitoneally (i.p.) according to an escalating dose (ED) schedule (from 1 to 10 mg/kg, 3 doses/day). We first confirmed the development of tolerance by monitoring DA efflux in the NAc in response to 5 and 10 mg/kg doses of D-amph administered during the ED schedule of drug administration and again in response to the 5 mg/kg dose of D-amph 72 h following the last 10 mg/kg D-amph injection. In a separate study, DA efflux in the NAc was first shown to be increased significantly during both preparatory and consummatory phases of responding for a 4% sucrose solution. Withdrawal from the ED schedule of D-amph caused a selective attenuation of DA efflux only during the preparatory phase of the sucrose test. These results provided convincing evidence of neurochemical adaptation within the mesocorticolimbic DA pathway during and following the administration of an ED schedule of D-amph as well as suppressed neurochemical responses to a psychostimulant drug and cues associated with a natural reward after withdrawal from drug treatment. Accordingly, these findings support the hypothesis that downregulation of mesocorticolimbic DA function maintained during D-amph withdrawal may account for the selective disruption of motivated behavior reported in studies employing psychostimulant drug withdrawal as a model of depression in rodents.
在人类和啮齿动物中,戒除高剂量精神兴奋剂药物会引发不良心理效应,包括快感缺失,这是重度抑郁症的核心症状,行为表现为对奖励性刺激的反应减少。本研究采用脑微透析技术,对自由活动的大鼠进行实验,以检测D-苯丙胺(D-安非他明)戒断对伏隔核(NAc)细胞外多巴胺(DA)水平变化的影响,这些变化由D-安非他明或与蔗糖消耗相关的行为诱发。按照递增剂量(ED)方案(从1至10mg/kg,每天3剂)腹腔注射(i.p.)D-安非他明。我们首先通过监测在药物递增剂量给药方案期间给予5mg/kg和10mg/kg剂量D-安非他明时伏隔核中的DA流出情况,以及在最后一次注射10mg/kg D-安非他明72小时后再次给予5mg/kg剂量D-安非他明时的DA流出情况,来确认耐受性的形成。在另一项研究中,首次发现伏隔核中的DA流出在对4%蔗糖溶液做出反应的准备阶段和 consummatory阶段均显著增加。从D-安非他明递增剂量方案中戒断仅在蔗糖测试的准备阶段导致DA流出选择性减弱。这些结果为在给予D-安非他明递增剂量方案期间及之后中脑边缘多巴胺通路内的神经化学适应性变化,以及在药物治疗戒断后对精神兴奋剂药物和与自然奖励相关线索的神经化学反应受到抑制,提供了令人信服的证据。因此,这些发现支持了这样一种假说,即在D-安非他明戒断期间维持的中脑边缘多巴胺功能下调,可能解释了在以精神兴奋剂药物戒断作为啮齿动物抑郁症模型的研究中所报道的动机行为的选择性破坏。